REVENUE (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020 USD ($)	Sep. 30, 2019 USD ($)	Sep. 30, 2020 USD ($) segment	Sep. 30, 2019 USD ($)	Dec. 31, 2019 USD ($)
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Number of reportable segments | segment			2
Revenue, net	$ 56,636	$ 31,237	$ 133,001	$ 88,894
Contract receivables, current	1,300		1,300		$ 1,100
Contract receivables, noncurrent	4,000		4,000		3,700
Current portion of deferred revenue, and other	8,200		8,200		$ 8,700
Contract liabilities, revenue recognized			3,400
Contract liabilities, increase due to additional deferred sales			2,300
Scil Animal Care Company
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Contract with customer, liability	600		600
North America
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue, net	34,450	29,605	91,081	84,492
International
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue, net	22,186	1,632	41,920	4,402
POC Lab Instruments & Other | North America
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue, net	2,458	1,916	5,772	5,222
POC Lab Instruments & Other | International
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue, net	2,643	1	4,759	17
Sales-type leases | North America
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue, net	1,310	1,587	3,574	4,821
Sales-type leases | International
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue, net	277	0	601	0
POC Lab Consumables | North America
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue, net	16,071	13,953	43,294	39,452
POC Lab Consumables | International
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue, net	11,387	70	21,418	94
POC Imaging | North America
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue, net	5,268	4,550	12,912	13,781
POC Imaging | International
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue, net	7,029	785	12,791	2,194
PVD | North America
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue, net	5,437	2,702	14,821	8,093
PVD | International
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue, net	850	776	2,351	2,097
OVP | North America
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue, net	3,906	4,897	10,708	13,123
OVP | International
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue, net	$ 0	$ 0	$ 0	$ 0